T-cell Lymphoma – How Should I Use New Agents in My Practice?
Description
Upon viewing this session, you will be able to:
• Review standard treatment options in the front-line setting for PTCL and discuss when to consider novel regimens
• Review the options for treatment of relapsed/refractory PTCL including agents or regimens in development
• Review standard treatment options in the front-line setting for PTCL and discuss when to consider novel regimens
• Review the options for treatment of relapsed/refractory PTCL including agents or regimens in development
Presenters
- Neha Mehta-Shah, MD, Washington University in St. Louis
Pricing
| Member Type | Price |
|---|---|
| List Price | $30.00 |
| Active, International, Emeritus, and Honorary Members | $20.00 |
| Associate, International Associate, Student, and Resident Members | $20.00 |
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2021 by American Society of Hematology